QuidelOrtho Corp

In Vitro & In Vivo Diagnostic Substances

QDEL Pharmaceuticals & Biotechnology People in Pharmaceuticals & Biotechnology SEC CIK 0001906324 ↗

Computed from SEC EDGAR filings and closing prices — not copied from any wealth ranking. Dataset . How we calculate this.

Market capitalisation
$807.82M
68,575,427 shares Covers every share class this company has on file.
Insiders on file
5
people who have filed Form 3, 4 or 5 naming this issuer
Value of insider-held stock
$2.97M
from the holdings reported on Forms 3/4/5; this figure has no separate as-of date on file
Insider-held share of market cap
0.37%
insider-held value divided by market capitalisation

What QuidelOrtho Corp reports

Revenue and net income below are for fiscal period FY2025, the period label carried by this company’s own annual XBRL filings to the SEC. Fiscal years do not line up between companies — one company’s FY2026 can cover much the same months as another’s FY2025 — so compare the periods, not just the numbers.

Revenue
$2.73B
FY2025 annual revenue, from this company’s own annual XBRL filings to the SEC
Net income
-$1.13B
FY2025 a loss for the period, from this company’s own annual XBRL filings to the SEC
Employees
6,500
Yahoo Finance
Where the employee count comes from

Headcount comes from Yahoo Finance, not from a filing. The date beside it is the day we retrieved the figure — it is not the date the company counted its staff, and Yahoo does not publish that date. Unlike the SEC filings behind the other figures on this page, this one carries no open licence, so we publish the number and nothing else from that source.

Insiders at QuidelOrtho Corp

Shares is what each person last reported holding here.

Everyone below has filed at least one insider report against this company.

Value is that share count priced at the same closing price used everywhere else on this site. A row priced from only some of a person’s securities says so — we do not quietly present a partial sum as a complete one.

People who file insider reports against QuidelOrtho Corp.
Insider Reported role Shares Value Last action
Kenneth F. Buechler Board Member 101,921 $1.42M A Grant or award Jun 6, 2026 position reported
Matthew Strobeck Board Member 82,550 $1.15M A Grant or award May 29, 2026 position reported
Ann D. Rhoads Board Member 15,021 $209.8K A Grant or award May 29, 2026 position reported
Evelyn S Dilsaver Evelyn S Dilsaver Board Member 10,624 $148.4K A Grant or award May 29, 2026 position reported
R Scott Huennekens Board Member 2,523 $35.2K A Grant or award May 29, 2026 position reported

Recent insider transactions

Of the 34 rows we hold, 2 are open-market purchases (P) and 0 open-market sales — the only codes we count as buying or selling.

The rest — awards, shares withheld to pay tax, option exercises, gifts and so on — follow from an employment contract or a transfer arranged off-market, not from a decision to buy or sell, so counting them would turn this into a pay table.

A price of 0.00 is a real reported figure on gifts (G) and share awards (A) — not a gap in our data.

Insider transactions disclosed to the SEC for QuidelOrtho Corp, newest first, each with the filing behind it.
Date Insider Transaction Shares Price Value Filing
Jun 6, 2026 Kenneth F. Buechler A Grant or award 497 $0.00 $0 SEC filing ↗
Jun 6, 2026 Kenneth F. Buechler A Grant or award 1,659 $0.00 $0 SEC filing ↗
May 29, 2026 Evelyn S Dilsaver A Grant or award 6,829 $0.00 $0 SEC filing ↗
May 29, 2026 Matthew Strobeck A Grant or award 6,829 $0.00 $0 SEC filing ↗
May 29, 2026 R Scott Huennekens A Grant or award 6,829 $0.00 $0 SEC filing ↗
May 29, 2026 Ann D. Rhoads A Grant or award 6,829 $0.00 $0 SEC filing ↗
May 29, 2026 Kenneth F. Buechler A Grant or award 6,829 $0.00 $0 SEC filing ↗
May 22, 2026 Ann D. Rhoads A Grant or award 234 $0.00 $0 SEC filing ↗
May 22, 2026 Ann D. Rhoads A Grant or award 1,173 $0.00 $0 SEC filing ↗
Feb 13, 2026 Matthew Strobeck P Open-market purchase 10,000 $23.96 $239.6K SEC filing ↗
Dec 10, 2025 Ann D. Rhoads P Open-market purchase 750 $28.28 $21.2K SEC filing ↗
Jul 15, 2025 Kenneth F. Buechler M Option exercise or conversion 9,215 $15.74 $145.0K SEC filing ↗
May 24, 2025 Ann D. Rhoads A Grant or award 546 $0.00 $0 SEC filing ↗
May 24, 2025 Ann D. Rhoads A Grant or award 109 $0.00 $0 SEC filing ↗
May 24, 2025 Evelyn S Dilsaver A Grant or award 80 $0.00 $0 SEC filing ↗
May 24, 2025 Evelyn S Dilsaver A Grant or award 402 $0.00 $0 SEC filing ↗
May 22, 2025 R Scott Huennekens A Grant or award 2,523 $0.00 $0 SEC filing ↗
May 22, 2025 Ann D. Rhoads A Grant or award 4,929 $0.00 $0 SEC filing ↗
May 22, 2025 Kenneth F. Buechler A Grant or award 4,929 $0.00 $0 SEC filing ↗
May 22, 2025 Matthew Strobeck A Grant or award 4,929 $0.00 $0 SEC filing ↗
May 22, 2025 Evelyn S Dilsaver A Grant or award 4,929 $0.00 $0 SEC filing ↗
May 18, 2025 Ann D. Rhoads A Grant or award 128 $0.00 $0 SEC filing ↗
May 18, 2025 Ann D. Rhoads A Grant or award 427 $0.00 $0 SEC filing ↗
May 18, 2025 Kenneth F. Buechler A Grant or award 236 $0.00 $0 SEC filing ↗
May 18, 2025 Kenneth F. Buechler A Grant or award 789 $0.00 $0 SEC filing ↗

From SEC Form 4 filings. Every row links to the filing it came from. How we calculate this.

What a Form 4 is

The report an officer, director or large shareholder must file after trading their own company’s stock.

Corporate ownership links — 9 filers hold a position

Who owns QuidelOrtho Corp

Each row is one filer naming this company.

Funds, trusts and other companies file the same ownership forms that executives do. Everything below is taken from those filings, with the position exactly as the filing states it.

Do not add these figures together. 9 of the positions below were reported on filings shared by several filers at once.

Why the same shares appear twice

On a joint filing every named filer is listed against the whole position, so the same block of stock appears under each name. Those rows are marked joint.

Filers holding a position in QuidelOrtho Corp

Funds, trusts and companies that disclose an ownership position in QuidelOrtho Corp.
Owner Reported role Shares Filed
Carlyle Group Inc. CG TenPercentOwner 0 joint
Carlyle Holdings II GP L.L.C. TenPercentOwner 0 joint
Carlyle Holdings II L.L.C. TenPercentOwner 0 joint
Carlyle Partners VI Cayman Holdings, L.P. TenPercentOwner 0 joint
CG Subsidiary Holdings L.L.C. TenPercentOwner 0 joint
TC Group Cayman Investment Holdings Sub L.P. TenPercentOwner 0 joint
TC Group Cayman Investment Holdings, L.P. Other,TenPercentOwner 0 joint
TC Group VI Cayman, L.L.C. TenPercentOwner 0 joint
TC Group VI Cayman, L.P. TenPercentOwner 0 joint

See the full ownership map — every entity that files as an owner of a US public company.

Subsidiaries — 67 legal entities

Subsidiaries of QuidelOrtho Corp

67 legal entities named in the subsidiary exhibit filed with this company’s most recent 10-K. . Filing on SEC.gov.

This is not the full list. SEC rules only require a company to name its significant subsidiaries.

What that leaves out

Smaller entities are left out of the exhibit entirely. A short list here means a short exhibit — it does not mean the company owns nothing else. Nothing on this page is inferred: every name below is copied from the filing.

Subsidiaries QuidelOrtho Corp names in its most recent annual report, with the place each one is organised.
Subsidiary Organised in
BioHelix Corporation Massachusetts, United States
Branch of Ortho-Clinical Diagnostics Netherlands B.V. Saudi Arabia
Crimson Germany GmbH Germany
Crimson International Assets LLC Delaware, United States
Crimson OCD (UK) Limited United Kingdom
Diagnostic Hybrids, Inc. Ohio, United States
Germany OCD Co GmbH Germany
Germany OCD Holding GmbH & Co. KG Germany
Immutopics, Inc. California, United States
Micro Typing Systems, Inc. Florida, United States
OCD Clinical Diagnostics Portugal, Unipessoal Lda Portugal
OCD Investment Holdings B.V. Netherlands
Orca Holdco 2, Inc. Delaware, United States
Orca Holdco, Inc. Delaware, United States
Ortho Clinical Diagnostics Biotechnology Development Shanghai Co. Ltd. China
Ortho Clinical Diagnostics Do Brasil Produtos Para Saude Ltda. Brazil
Ortho Clinical Diagnostics India Private Limited India
Ortho-Clinical Diagnostics United Kingdom
Ortho-Clinical Diagnostics (Thailand) Ltd. Thailand
Ortho-Clinical Diagnostics Australia Pty Ltd. Australia
Ortho-Clinical Diagnostics Chile SpA Chile
Ortho-Clinical Diagnostics Colombia SAS Colombia
Ortho-Clinical Diagnostics Czech s.r.o. Czech Republic
Ortho-Clinical Diagnostics Denmark, filial af Ortho-Clinical Diagnostics Netherlands B.V. Denmark
Ortho-Clinical Diagnostics Egypt for Trading & Importation LLC Egypt
Ortho-Clinical Diagnostics Egypt Investment LLC Egypt
Ortho-Clinical Diagnostics Egypt Services LLC Egypt
Ortho-Clinical Diagnostics FinCo S.à r.l. Barbados
Ortho-Clinical Diagnostics France SAS France
Ortho-Clinical Diagnostics GmbH Austria
Ortho-Clinical Diagnostics Holdings Luxembourg S.à r.l. Luxembourg
Ortho-Clinical Diagnostics Italy S.r.l. Italy
Ortho-Clinical Diagnostics K.K. Japan
Ortho-Clinical Diagnostics Limited Liability Company Russia
Ortho-Clinical Diagnostics Luxembourg S.à r.l. Luxembourg
Ortho-Clinical Diagnostics MEA Dubai
Ortho-Clinical Diagnostics Medical Technology (Changsha) Co., Ltd. China
Ortho-Clinical Diagnostics Mexico Operations S. de R.L. de C.V. Mexico
Ortho-Clinical Diagnostics Mexico Services S. de R.L. de C.V. Mexico
Ortho-Clinical Diagnostics Netherlands B.V. Netherlands
Ortho-Clinical Diagnostics Norway (branch of Ortho-Clinical Diagnostics Netherlands B.V.) Norway
Ortho-Clinical Diagnostics NV Belgium
Ortho-Clinical Diagnostics Panama Export S.A. Panama
Ortho-Clinical Diagnostics Panama S.A. Panama
Ortho-Clinical Diagnostics Philippines Inc. Philippines
Ortho-Clinical Diagnostics S.à r.l. Luxembourg
Ortho-Clinical Diagnostics Singapore Pte. Ltd. Singapore
Ortho-Clinical Diagnostics Spain, S.L. Spain
Ortho-Clinical Diagnostics Sweden AB Sweden
Ortho-Clinical Diagnostics Switzerland GmbH Switzerland
Ortho-Clinical Diagnostics Trading (China) Co. Ltd. China
Ortho-Clinical Diagnostics U.S. FinanceCo I, LLC Delaware, United States
Ortho-Clinical Diagnostics, Inc. New York, United States
Quidel Cardiovascular Inc. Delaware, United States
Quidel Corporation Delaware, United States
Quidel Diagnostics India Private Limited India
Quidel France SARL France
Quidel Germany, GmbH Germany
Quidel Hong Kong, Ltd. Hong Kong
Quidel International, LLC Delaware, United States
Quidel Ireland Limited Ireland
Quidel Italy SRL Italy
Quidel Services, LLC Delaware, United States
QuidelOrtho Canada Corporation Canada
QuidelOrtho Health Operational Services Limited Company Turkey
QuidelOrtho Regional Headquarters Company Saudi Arabia
QuidelOrtho Sales Company, LLC Delaware, United States
What counts as a subsidiary

A subsidiary is a separate legal entity this company controls; it is not the same thing as a brand, a division or an office. These entities do not file with the SEC in their own right, so there is no separate page to open for them.

Think a number here is wrong? Open the linked filing and compare — how to report it.

Sources and technical notes

Every figure on this page comes from filings to the U.S. SEC via EDGAR. Nothing here is estimated, and nothing is taken from press coverage or company websites.

Share count: cover page of the latest filing (dei:EntityCommonStockSharesOutstanding), taken from QuidelOrtho Corp’s own filings and multiplied by our closing price. Full method.

What that share count means

the share count the company itself prints on the cover of its most recent filing, as of the date it signed that filing.

We do not take a market cap from a data vendor, and we do not estimate one: the figure is a share count from QuidelOrtho Corp’s own SEC filings multiplied by the closing price we hold for the same stock.